Article
Navigating diagnostic shifts: A comparative review of the WHO 5th edition and ICC 2022 classifications of myeloid neoplasms.
Human pathology - 1 Mar 2026
Koorse Germans Sharon, Weinberg Olga K
Abstract excerpt
The near-simultaneous publication of the World Health Organization (WHO) 5th Edition classification of hematolymphoid tumors (WHO-HAEM5) and the International Consensus Classification (ICC) in 2022 represents a pivotal moment in the taxonomy of myeloid neoplasms. Both systems emphasize integration of morphology, cytogenetics, and molecular genetics, yet they diverge in several clinically meaningful areas,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
